The Popularity of the Insulin Pen

“The synergies created between pharmaceutical and medical device companies will be a key driver of the insulin pens market in Europe,” notes Kieu Vuong, Research Analyst at Frost & Sullivan. “Another significant factor spurring growth is that insulin pens are more compatible with the fast paced modern environment.” The convenience of using insulin pens corresponds well to today’s user needs: a high level of flexibility and little commitment required in terms of time and effort. Use of the oldest delivery method, insulin syringes, is declining, mainly due to needle phobia amongst all users, whether children or adults.

The vast majority of insulin pens are given to patients free when they purchase insulin. This means that suppliers of insulin have a huge impact on the popularity and awareness of the related delivery devices. Insulin delivery device manufacturers need to work together with pharmaceutical companies to successfully distribute and promote their products, recommends new market analysis from Frost & Sullivan.

“One of the biggest and most important challenges for manufacturers of emerging insulin delivery devices is to build a close business relationship with pharmaceutical companies,” advises Vuong. “Insulin pens are a good example of this kind of cooperation.”

Through cooperative agreements and projects, both companies can benefit from mutual synergies and save on additional capital investments and operation costs, even while extending their product portfolio.

For an overview of the European insulin delivery devices market, send an email to katja.feick@frost.com.

Tags: Drug delivery, Insulin pen